Determination of the profile of metabolites of medicinal plants rich in tannins in the context of their antineurodegenerative activity

E.v. Kysil, V.v. Chantseva, Denys Gorbach, A.k. Wailey, Anastasia Orlova, V.n. Babakov, Elena V. Romanovskaya, V.g. Lujanin, M.n. Povyshysh, Tatiana Bilova, L.a. Vessyohann, Alexey FrolovIX 2019 · DOI

Abstract

Neurodegenerative diseases like Alzheimer’s and Parkinson’s are increasingly prevalent in aging populations, driven largely by oxidative stress and toxic protein accumulation. This study maps the complex chemical fingerprints of eight tannin-rich medicinal plants to evaluate their neuroprotective potential. Using human neuroblastoma cell models (SH-SY5Y), researchers identified specific plant fractions that significantly protect neurons from oxidative damage and apoptosis. These findings provide a molecular foundation for developing new plant-derived therapeutic agents.

Introduction: The Challenge of Neurodegeneration

Neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases represent some of the most daunting health challenges of our time. A primary driver of these pathologies is oxidative stress—the accumulation of reactive oxygen species (ROS) that damage vital cellular components. While current pharmaceuticals often focus on managing symptoms, there is a critical need for neuroprotective strategies that can prevent or slow neuronal death.

Medicinal plants, particularly those rich in tannins and other polyphenols, offer a promising "natural pharmacy." These compounds are renowned for their antioxidant properties. However, moving from traditional knowledge to modern medicine requires identifying the specific metabolites that provide protection. This study bridges that gap by applying advanced analytical chemistry to botanical extracts.

Medicinal plants and cellular models represent the dual focus of this neuroprotection research.

Methodology: A Multi-Disciplinary Pipeline

The researchers employed a sophisticated experimental pipeline combining analytical chemistry with functional cell biology:

  1. Fractionation: Metabolites from eight medicinal plants were extracted and separated into polar, semi-polar, and tannin-rich fractions to isolate specific bioactive groups.
  2. Metabolite Profiling: The team used Gas Chromatography (GC) and Liquid Chromatography-Mass Spectrometry (LC-MS) to characterize the chemical diversity of the samples, identifying the unique molecular signatures of each fraction.
  3. Cellular Modeling: The SH-SY5Y human neuroblastoma cell line served as the primary model for studying neuronal function and response to stress.
  4. Disease Induction:
    • Parkinson’s Model: Cells were treated with 1-methyl-4-phenylpyridinium (MPP+) or induced to overexpress α-synuclein.
  5. Alzheimer’s Model: Cells were exposed to β-amyloid peptide (25-35).
  6. Evaluation: Neuroprotective effects were quantified by monitoring cell viability, rates of apoptosis (programmed cell death), and the production of ROS.
Microscopic view of cellular structures, similar to the SH-SY5Y neuroblastoma line used for disease modeling.

Key Results and Insights

The study successfully characterized the metabolite profiles of the eight plants, identifying over 200 reactive carbonyl compounds within the extracts. Qualitative findings confirmed that specific tannin-rich and polyphenolic fractions significantly improved cell viability and reduced apoptosis when cells were exposed to neurotoxins.

Several key insights emerged:

  • Fractional Efficacy: Neuroprotection is not uniform across the whole plant; specific fractions (especially those rich in tannins) showed distinct levels of efficacy, suggesting that the synergy of certain compounds is vital.
  • Broad-Spectrum Protection: The fact that certain fractions worked in both Parkinson’s and Alzheimer’s models suggests a broad-spectrum neuroprotective mechanism, likely centered on mitigating oxidative stress.
  • Molecular Pharmacology: By using high-resolution mass spectrometry, the research moves beyond traditional herbalism, pinpointing the specific chemical signatures associated with neuronal survival.

Limitations and Future Directions

While these results are promising, they are currently limited to in vitro models. Cell cultures do not fully replicate the complexity of the human brain, nor do they account for the blood-brain barrier (BBB), which many large polyphenols struggle to cross.

Future work will focus on:

  • Identifying specific "lead compounds" within the successful fractions.
  • Testing these compounds in animal models to evaluate their ability to cross the BBB and remain active after digestion.
  • Investigating anti-inflammatory properties, as neurodegeneration is closely linked to chronic brain inflammation.

Summary updated

BibTeX
@inproceedings{kysil2019determination,
  author = {E.V. Kysil and V.V. Chantseva and Denys Gorbach and A.K. Wailey and Anastasia Orlova and V.N. Babakov and Elena V. Romanovskaya and V.G. Lujanin and M.N. Povyshysh and Tatiana Bilova and L.A. Vessyohann and Alexey Frolov},
  title = {{Determination of the profile of metabolites of medicinal plants rich in tannins in the context of their antineurodegenerative activity}},
  booktitle = {IX},
  year = {2019},
  doi = {10.26907/978-5-00130-204-9-2019-212},
}
Figure